20
Cipla Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Sumatriptan succinate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2010-167 - Rev 01
This Chemical Type CEP, issued on July 28, 2014, remains in force until October 05, 2016, ensuring its reliability within the pharmaceutical industry.
Substance Number 1573 associated with this CEP further emphasizes